Glycomics market : Technological Advancements in Glycomics Instrumentation
The growth of this market is majorly driven by the increasing research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment.
- The global glycomics market is estimated to grow from USD 1.0 billion in 2020 to USD 2.0 billion by 2025, at a CAGR of 13.8%.
Browse 194 market data Tables and 29 Figures spread through 173 Pages and in-depth
Download PDF Brochure Now: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132685525
glycomics market DRIVERS :
- Increasing R&D Expenditure and Funding for Proteomics and Glycomics Research
- Growth of the Proteomics Market
- Technological Advancements in Glycomics Instrumentation
Based on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.
Request Sample Report of glycomics market : https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525
The geographical regions mapped in the report are:
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Rest of the World (RoW)
Regional Growth, Development and Demand Analysis:
The global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global market, followed by Europe.
Key Market Players
The prominent players operating in the glycomics market include Merck KGaA (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), New England Biolabs (US), Shimadzu Corporation (Japan), Takara Bio (Japan), S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan), Waters Corporation (US), Asparia Glycomics S.L. (Spain), Bio-Techne (US), Bruker Corporation (US), Danaher Corporation (US), RayBiotech (US), Z Biotech (US), Chemily Glycoscience (US), Dextra Laboratories (UK), Lectenz Bio (US), and Ludger Ltd. (UK).
Merck was the leading player in the market in 2018. Strong business operations across all key regions, coupled with a strong brand image, have made Merck a leading player in this market. Over the last few years, the company has been focusing on R&D activities and invested approximately 2.5–4.0% of its life science revenue on R&D activities. The company has a strong presence in North America and generated 35.1% of its total life science revenue from the North American market in 2018. Also, the company is making strategic investments in high-growth Asian markets to strengthen its Life Science business segment.
Scope of the ReportBased on application, the glycomics market is segmented into drug discovery & development, disease diagnostics, and other applications. Drug discovery & development is the largest and the fastest-growing application segment in the market, majorly due to the increasing R&D investments in pharmaceutical and biotechnology companies and the growing number of drug discovery research activities in academic research institutes.